Investigators to Present Preliminary Findings for Adaptimmune’s Gene Engineered T Cells in Myeloma

News   Nov 19, 2012

 
Investigators to Present Preliminary Findings for Adaptimmune’s Gene Engineered T Cells in Myeloma
 
 
 

RELATED ARTICLES

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

Scientists Reveal the Relationship Between Sugar and Cancer

News

By analysisng metabolites scientists have clarified how the Warburg effect, a phenomenon in which cancer cells rapidly break down sugars, stimulates tumor growth.

READ MORE

Expanded Potential Stem Cells Created

News

Scientists have created Expanded Potential Stem Cells (EPSCs) that, for the first time, can produce all three types of blastocyst stem cells - embryo, placenta and yolk sac.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE